Beruflich Dokumente
Kultur Dokumente
Reporting Interface
Specifications
HL7 ORU Message Version 2.5.1
athenahealth, Inc.
Version 1.0 Published: December 2014
Inbound Observation Reporting Interface Specifications
Table of Contents
TABLE OF CONTENTS..........................................................................................................................................................................2
1.0 – INTRODUCTION............................................................................................................................................................................3
1.1 – OVERVIEW.......................................................................................................................................................................................3
1.2 – CONNECTIVITY................................................................................................................................................................................3
1.3 – ATHENANET MESSAGE EXCHANGE (MX) ENGINE..........................................................................................................................3
1.4 – HL7 MESSAGE VERSIONING............................................................................................................................................................3
2.0 – HL7 ORU MESSAGE SPECIFICATIONS...................................................................................................................................4
2.1 – TRIGGER EVENTS.............................................................................................................................................................................4
2.2 – MESSAGE DEFINITION.....................................................................................................................................................................4
2.3 – MESSAGE FORMAT..........................................................................................................................................................................5
3.0 – SEGMENT MAPPINGS..................................................................................................................................................................5
3.1 – MSH MESSAGE HEADER SEGMENT................................................................................................................................................5
3.2 – PID PATIENT IDENTIFICATION SEGMENT........................................................................................................................................7
3.3 – PD1 ADDITIONAL DEMOGRAPHICS SEGMENT.................................................................................................................................8
3.4 – PV1 PATIENT VISIT SEGMENT.........................................................................................................................................................9
3.5 – ORC ORDER COMMON SEGMENT.................................................................................................................................................11
3.6 – OBR OBSERVATION REQUEST SEGMENT......................................................................................................................................13
3.7 – OBX OBSERVATION/RESULT SEGMENT........................................................................................................................................15
3.8 – SPM SPECIMEN SEGMENT.............................................................................................................................................................16
3.9 – NTE NOTES AND COMMENTS SEGMENT.......................................................................................................................................17
4.0 – EXAMPLES OF USE.....................................................................................................................................................................18
4.1 – AMYLASE, SERUM.........................................................................................................................................................................18
4.2 – RAPID STREP GROUP A, THROAT..................................................................................................................................................19
4.3 – CULTURE WITH SENSITIVITY PANEL.............................................................................................................................................20
4.4 – CULTURE WITH SENSITIVITY PANEL IN ONE OBR........................................................................................................................21
5.0 – CHANGE LOG...............................................................................................................................................................................22
5.1 – NEW SEGMENT SUPPORT...............................................................................................................................................................22
5.2 – SPM SEGMENT CHANGES..............................................................................................................................................................22
5.3 – OBX SEGMENT CHANGES.............................................................................................................................................................22
1.0 – Introduction
1.1 – Overview
This document describes the implementation of an application interface using Health Level Seven’s (HL7) ORU message specifications.
athenahealth's observation reporting interface is a unidirectional interface that is utilized for result messages to be sent outbound from a third party
trading partner and inbound to athenaNet. The use-case for the observation reporting interface encompasses all types of laboratory results, imaging
results, and clinically related documentation.
During the interface implementation project, this document should be used as a compliment to the implementation guides that can be found on
athenahealth’s interfaces web page.
1.2 – Connectivity
athenahealth offers a variety of connectivity options to the athenaNet MX Engine, which is athenahealth’s system tool for exchanging data over an
interface. Data exchange partners should work directly with their athenahealth interface project manager to determine and execute a connectivity
plan.
The athenaNet MX Engine is athenahealth’s mechanism for the exchange of HL7 messages. All necessary functionality to receive, process, and
acknowledge an inbound ORU message is implemented using the athenaNet MX Engine.
This guide discusses the processing of an inbound ORU message as it relates to HL7’s 2.5.1 message specifications. The athenaNet MX Engine is
backwards compatible with HL7 versions 2.2, 2.3, 2.3.1, 2.4, and 2.5.
The athenaNet MX Engine processes inbound ORU messages for laboratory, imaging, and clinical document result-types in athenaNet. Trigger
events that are supported include both R01 (for unsolicited observation messages) and R03 (display-oriented results, query/unsolicited update for
backward compatibility only) events.
The segment ordering for a 2.5.1 ORU^R01 (unsolicited observation) message is noted below. Segments relevant for default processing done by the
athenaNet MX Engine are denoted using bold text. For the athenaNet MX Engine, segments that are optional are enclosed with brackets ( [ ] ) while
segments enclosed in braces ( { } ) indicate the segment is repeatable.
[ SFT ] Software
[ TQ1 ] Timing/Quantity
[ { OBX } ] Observation/Result
[ { SPM } ] Specimen
The athenaNet MX engine will process information in the segments described in section 3.0 – Segment Mappings. Segments are omitted from this
guide if the athenaNet MX engine does not by default process information within that segment. If additional segments or fields are in need of being
processed, please discuss this with your athenahealth Interface Project Manager.
The MSH segment is used to identify information related to the message including the source, destination, and other specific items regarding the
interface message.
For an ORU message type, the athenaNet MX Engine uses the PID segment to associate the result with a patient in athenaNet. First name, last name,
and date of birth are the criteria used by the athenaNet MX Engine for patient matching logic.
For an ORU message type, the athenaNet MX Engine will use the PD1 segment only when looking for an athenaNet provider to associate with the
result message.
For an ORU message type, the athenaNet MX Engine will use the PV1 segment only when looking for an athenaNet provider to associate with the
result message.
For an ORU message type, the athenaNet MX Engine will use the ORC segment only when looking for an athenaNet provider to associate with the
result message.
The OBR segment contains information relevant to the originating order for the result message. It is a header of the result document.
The OBX segment is used to transmit a single observation or observation fragment that is associated with the result document.
The athenaNet MX Engine uses the SPM segment to process and display information related to the specimen.
This field is
interpreted as the
SPM-8 Specimen Source Site
‘Specimen Source’ on
a result document.
This field is
interpreted as the
SPM-18 Specimen Received Date/Time
‘Specimen Rec. Date’
on a result document.
The NTE segment is used to display notes specific to the specimens, observation fragments, or the originating order. These notes will display on
result documents as result notes or notes from the laboratory.
MSH|^~\&|LAB|NASON|Athena|2964|20141023133254-0600||ORU^R01^ORU_R01|20087.3|D|2.5.1|||AL|NE|||||
LRI_NG_RU_Profile^HL7^2.16.840.1.113883.9.19^ISO
PID|1||V001047^^^&&ISO^MR^&&ISO~T00001059^^^&&ISO^XX^&&ISO~V00018739^^^&&ISO^AN^&&ISO||test^patient^^^^^L||19870711|M||2131-1^Other
Race^HL70005|^^^^^USA^H|||||||||||||||||||N|||201410061026-0600|VVH^^ISO
NTE|1|P|testing|RE^Remark^HL70364^C^Comment^L^2.5.1^V1
ORC|RE|1618-1^LAB.VVH^^ISO|1023:RC00001R-1^LAB.VVH^^ISO|1023:RC00001R^2060^^ISO||N|||20141023133254-0600|||
SMIJ^SMITH^JOHN^^^^MD^^MIS&&ISO^L^^^XX^&&ISO^^^^^^^MD||^WPN^PH^^1^970^3286357^^Hospital Line|201410231322-0600||Main Lab|
13045VVH|||Main Lab^L|Valley View Hospital^1906 Blake Ave.^Glenwood Spgs^CO^81601^USA^B|^WPN^PH^^1^970^3847590|Eagle Valley Medical Clinic^377
Sylvan Lake Road^Eagle^CO^81631^USA^B
OBR|1|1618-1^LAB.VVH^^ISO|1023:RC00001R-1^LAB.VVH^^ISO|AMY^AMYLASE^L^^^^2.40^1.2^AMYLASE| ||201410231322-0600|201410231322-0600||scj|
O|||201410231510-0600||SMIJ^SMITH^JOHN^^^^MD^^MIS&&ISO^L^^^XX^&&ISO^^^^^^^MD|^WPN^PH^^1^970^3286357^^Hospital Line|00001532|||Main
Lab|20141023133200-0600||LAB|C
TQ1|1||||||201410231322-0600|201410231322-0600|R
OBX|1|NM|AMY^AMYLASE^L^^^^2.40^1^AMYLASE||1002|U/L^enzyme unit per liter^UCUM^U/L^U/L^L|25-115|H|||C|||201410231322-0600|ML^Main Lab^L|
A^^AMYLASE^AMYLASE^55435.000|||201410231332-0600||||Main Lab^D^^^^CLIA&2.16.840.1.113883.4.7&ISO|Valley View Hospital^1906 Blake
Ave.^Glenwood Spgs^CO^81601^USA^B|^Refior^Jeanette^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^VVH&&ISO
NTE|1|L|--- 10/23/14 1332 ---|RE^Remark^HL70364^^^^2.5.1
NTE|2|L|AMYLASE previously reported as:|RE^Remark^HL70364^^^^2.5.1
NTE|3|L| 102 U/L|RE^Remark^HL70364^^^^2.5.1
NTE|4|L||RE^Remark^HL70364^^^^2.5.1
SPM|1|00001532&&&ISO^2060&&&ISO|1023:RC00001R^2060|Saliva|||||||||||||201410231322-0600^201410231322-0600|201410231510-0600||||||||0.1|^GREEN GEL
(LI)
MSH|^~\&|LAB|NASON|Athena|2964|20141107124810-0600||ORU^R01^ORU_R01|21391.1|D|2.5.1|||AL|NE|||||
LRI_NG_RU_Profile^HL7^2.16.840.1.113883.9.19^ISO
PID|1||V001047^^^&&ISO^MR^&&ISO~T00001059^^^&&ISO^XX^&&ISO~V00018739^^^&&ISO^AN^&&ISO||test^patient^^^^^L||19870711|M||2131-1^Other
Race^HL70005|^^^^^USA^H|||||||||||||||||||N|||201410280855-0600|VVH^^ISO
NTE|1|P|Message Testing from Lab|RE^Remark^HL70364^C^Comment^L^2.5.1^V1
ORC|RE|1718-1^LAB.VVH^^ISO|14:MR0005021R-1^LAB.VVH^^ISO|14:MR0005021R^2149^^ISO||N|||201411071248-0600|||
SMIJ^SMITH^JOHN^^^^^^MIS&&ISO^L^^^XX^^^^^^^^MD||^WPN^PH^^1^970^3286357^^Hospital Line|201411071244-0600||Main Lab|13045VVH|||Main
Lab^L|Valley View Hospital^1906 Blake Ave.^Glenwood Spgs^CO^81601^^B|^WPN^PH^^1^970^3847590|Eagle Valley Medical Clinic^377 Sylvan Lake
Road^Eagle^CO^81631^USA^B
OBR|1|1718-1^LAB.VVH^^ISO|14:MR0005021R-1^LAB.VVH^^ISO|GAS^GRP A STREP SCREEN-RAPID^L^GAS^GRP A STREP SCREEN-
RAPID^L^2.40^^GRP A STREP SCREEN-RAPID|||201411071244-0600|201411071244-0600||scj|O|||201411071356-0600||
SMIJ^SMITH^JOHN^^^^^^MIS&&ISO^L^^^XX^^^^^^^^MD|^WPN^PH^^1^970^3286357^^Hospital Line|00001616||MR|Main Lab|20141107124700-0600||MB|
X|||||||
NTE|1|QRY|Extra Note from Lab
TQ1|1||||||201411071244-0600|201411071244-0600|R
OBX|1|ST|GAS^RAPID GROUP A STREP:^L||POSITIVE|||A|||X|||201411071244-0600|ML^Main Lab||||201411071245-0600||||Main
Lab^D^^^^CLIA&2.16.840.1.113883.4.7&ISO|Valley View Hospital^1906 Blake Ave.^Glenwood Spgs^CO^81601^USA^B|
^Refior^Jeanette^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^VVH&&ISO
SPM|1|00001616&&&ISO^2149&&&ISO|14:MR0005021R^2149|UDENT^Source, Unidentified^HL70487^RTT^THROAT^L^20100831^2.5.1^RTT|||||||||||||
201411071244-0600^201411071244-0600|291411071356-0600||||||||2|^EIA TEST MIC
athenaNet creates unique result documents for cultures and their sensitivity panels. It is recommended to use a TX-type OBX segment at the
beginning of the sensitivity panel OBR to indicate the organism that is associated to the panel.
MSH|^~\&|LAB|NASON|Athena|2964|20141118091100-0700||ORU^R01^ORU_R01|21628.4|D|2.5.1|||AL|NE|||||
LRI_NG_RU_Profile^HL7^2.16.840.1.113883.9.19^ISO
PID|1||V001047^^^&&ISO^MR^&&ISO~T00001059^^^&&ISO^XX^&&ISO~V00018739^^^&&ISO^AN^&&ISO||test^patient^^^^^L||19870711|M||2131-1^Other
Race^HL70005|^^^^^USA^H|||||||||||||||||||N|||201410280855-0700|VVH^^ISO
ORC|RE|1720-1^LAB.VVH^^ISO|14:AR0009135R-1^LAB.VVH^^ISO|14:AR0009135R^2151^^ISO||N|||201411180911-0700|||
SMIJ^SMITH^JOHN^^^^^^MIS&&ISO^L^^^XX^^^^^^^^MD||^WPN^PH^^1^970^3286357^^Hospital Line|201411071405-0700||Main Lab|14134VVH|||Main
Lab^L|Valley View Hospital^1906 Blake Ave.^Glenwood Spgs^CO^81601^^B|^WPN^PH^^1^970^3847590|Eagle Valley Medical Clinic^377 Sylvan Lake
Road^Eagle^CO^81631^USA^B
OBR|1|1720-1^LAB.VVH^^ISO|14:AR0009135R-1^LAB.VVH^^ISO|XXUC^URINE CULTURE^L^XXUC^URINE CULTURE^L^2.40^^URINE CULTURE| ||
201411071405-0600|201411071405-0600||SELTEST|O|||||SMIJ^SMITH^JOHN^^^^^^MIS&&ISO^L^^^XX^^^^^^^^MD|^WPN^PH^^1^970^3286357^^Hospital
Line|00001618||MBAR|Main Lab|20141118091000-0700||MB|A
TQ1|1||||||201411071405-0700|201411071405-0700|R
OBX|1|CWE|^^^^^^^^URINE CULTURE|1|ESCHERICHIA COLI^O:EC-1^L^EC-1^ESCHERICHIA COLI^L^2014111809^^ESCHERICHIA COLI|||||||||
201411071405-0700|ML^Main Lab||||201411180910-0700||||Main Lab^D^^^^CLIA&2.16.840.1.113883.4.7&ISO|Valley View Hospital^1906 Blake Ave.^Glenwood
Spgs^CO^81601^USA^B|^Refior^Jeanette^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^VVH&&ISO
NTE|1|L|COLONY COUNT >100,000 CFU/ML, 1 COLONY TYPE(S),|RE^Remark^HL70364^^^^2.5.1
NTE|2|L| ESCHERICHIA COLI 73114010|RE^Remark^HL70364^^^^2.5.1
SPM|1|00001618&&&ISO^2151&&&ISO|14:AR0009135R^2151| ||||||||||||||201411071405-0700
OBR|2|1720-2^LAB.VVH^^ISO|14:AR0009135R-2^LAB.VVH^^ISO|XXMSN^ID/MIC NEG^L^XXMSN^ID/MIC NEG^L^2.40^^ID/MIC NEG| ||201411071405-
0600|201411071405-0600||SELTEST|O|||||SMIJ^SMITH^JOHN^^^^^^MIS&&ISO^L^^^XX^^^^^^^^MD|^WPN^PH^^1^970^3286357^^Hospital Line|00001618||
MBAR|Main Lab|20141118091000-0700||MB|A|&&&&&&&&URINE CULTURE^1|||1720-1&LAB.VVH&&ISO^14:AR0009135R-1&LAB.VVH&&ISO|||
27097&UNKNOWN&U&Lauck&Susan&&&&&&ISO
OBX|1|TX|||Organism: ESCHERICHIA||||||F
OBX|2|SN|AM^AMPICILLIN^L^AM^AMPICILLIN^L^2.40^^AMPICILLIN|1|>16|||R||||||201411071405-0700|ML^Main Lab||||201411180910-0700||||Main
Lab^D^^^^CLIA&2.16.840.1.113883.4.7&ISO|Valley View Hospital^1906 Blake Ave.^Glenwood Spgs^CO^81601^USA^B|
^Refior^Jeanette^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^VVH&&ISO
OBX|3|SN|CFZ^CEFAZOLIN^L^CFZ^CEFAZOLIN^L^2.40^^CEFAZOLIN|1|<8|||S||||||201411071405-0700|ML^Main Lab||||201411180910-0700||||Main
Lab^D^^^^CLIA&2.16.840.1.113883.4.7&ISO|Valley View Hospital^1906 Blake Ave.^Glenwood Spgs^CO^81601^USA^B|
^Refior^Jeanette^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^VVH&&ISO
athenahealth’s inbound ORU interface processes information in segments denoted in bold text in 2.2 – Message Definition. Segments that
adhere to a 2.5.1 ORU message, R01 trigger event will parse through the athenaNet MX Engine although information is not read from all
segments. New segments that can be sent include SFT, TQ1, TQ2, CTD, FT1, and SPM. See 2.2 – Message Definition for segment
ordering.
Specimen Received Date and Time – Regarding the display of the Specimen Received Date and Time field, OBR-14 is available to be used
for backwards compatibility. The athenaNet MX Engine will by default look to SPM-18 for the Specimen Received Date and Time.
Specimen Source – Regarding the display of the Specimen Source field, OBR-15 is available to be used for backwards compatibility. The
athenaNet MX Engine will by default look to SPM-8 for the Specimen Source.
OBX-23, OBX-24, and OBX-25 are now used to display in the ‘Performing Lab’ section of a result document.